Lyra Therapeutics, Inc. (LYRA) › Shareholders' EquityLyra Therapeutics, Inc. (LYRA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$107.07M2019: -$123.34M2020: $74.49M2021: $34.32M2022: $80.75M2023: $89.42M2024: $11.59M2025: -$10.72M-$10.72M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$10.72M-192.4%2024$11.59M-87.0%2023$89.42M+10.7%2022$80.75M+135.3%2021$34.32M-53.9%2020$74.49M+160.4%2019-$123.34M-15.2%2018-$107.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share